WASHINGTON, DC—A transcatheter electrosurgical procedure that mimics surgical myotomy may be an option in some patients to relieve left ventricular outflow tract (LVOT) obstruction in the setting of ...
Please provide your email address to receive an email when new articles are posted on . Two weeks of metoprolol improved left ventricular outflow tract gradients, symptoms and quality of life compared ...
The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic ...
Patients with obstructive hypertrophic cardiomyopathy (HCM) who took an investigational agent that targets cardiac myosin over about 7 months showed across-the-board improvements in functional ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Clinical Trials Arena on MSN
BMS reports positive results in Phase III SCOUT-HCM trial for oHCM
The trial achieved its primary endpoint, showing a statistically significant reduction in Valsalva LVOT gradient at week 28.
Pharmaceutical Technology on MSN
Cytokinetics receives FDA approval for MYQORZO tablets for oHCM
Cytokinetics has announced that the US Food and Drug Administration (FDA) has approved MYQORZO (aficamten) tablets in 5mg, 10mg, 15mg, and 20mg doses for adults with symptomatic obstructive ...
ACCURATE diagnosis of obstruction to the outflow tract from the left ventricle was not considered necessary until the development of extracorporeal circulation and open-heart surgery. The diagnosis of ...
For palpation, use your fingertips or the area between the metacarpophalangeal and proximal interphalangeal joints. Practice and attention will determine which area is most sensitive for you. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results